Neil Gallagher, MD PhD, Joins Astex as Director of Clinical Development


CAMBRIDGE, United Kingdom, March 7, 2005 (PRIMEZONE) -- Astex Technology Ltd:

 -- Astex Technology, the fragment-based drug discovery and development 
    company, today announced the appointment of Neil Gallagher, MD PhD, 
    as Director of Clinical Development

 -- Dr. Gallagher will be responsible for implementing clinical plans 
    for the development of Astex's pipeline of novel drug candidates, 
    the first of which is targeted to enter Phase I clinical trials 
    later this year

 -- His excellent track record in clinical development and translational 
    research in oncology at AstraZeneca will help to accelerate the 
    clinical development of Astex's portfolio of molecularly-targeted 
    oncology drugs

Full press release attached below:


Contact Data